#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-9	Decreased	_
1-2	10-21	Hemispheric	_
1-3	22-34	Connectivity	_
1-4	35-38	and	_
1-5	39-48	Decreased	_
1-6	49-55	Intra-	_
1-7	56-59	and	_
1-8	60-66	Inter-	_
1-9	67-77	Hemisphere	_
1-10	78-87	Asymmetry	_
1-11	88-90	of	_
1-12	91-98	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-13	99-104	State	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-14	105-115	Functional	_
1-15	116-123	Network	_
1-16	124-136	Connectivity	_
1-17	137-139	in	_
1-18	140-153	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-19	154-158	Many	_
1-20	159-166	studies	_
1-21	167-171	have	_
1-22	172-177	shown	_
1-23	178-182	that	_
1-24	183-196	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-25	197-205	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-26	206-210	have	_
1-27	211-219	aberrant	_
1-28	220-230	functional	_
1-29	231-238	network	_
1-30	239-251	connectivity	_
1-31	252-253	(	_
1-32	254-257	FNC	_
1-33	258-259	)	_
1-34	260-265	among	_
1-35	266-271	brain	_
1-36	272-279	regions	_
1-37	280-281	,	_
1-38	282-292	suggesting	_
1-39	293-306	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-40	307-316	manifests	_
1-41	317-321	with	_
1-42	322-335	significantly	_
1-43	336-346	diminished	_
1-44	347-348	(	_
1-45	349-351	in	_
1-46	352-360	majority	_
1-47	361-363	of	_
1-48	364-367	the	_
1-49	368-373	cases	_
1-50	374-375	)	_
1-51	376-388	connectivity	_
1-52	389-390	.	_

2-1	391-404	Schizophrenia	_
2-2	405-407	is	_
2-3	408-412	also	_
2-4	413-423	associated	_
2-5	424-428	with	_
2-6	429-430	a	_
2-7	431-435	lack	_
2-8	436-438	of	_
2-9	439-450	hemispheric	_
2-10	451-465	lateralization	_
2-11	466-467	.	_

3-1	468-476	reported	_
3-2	477-482	lower	_
3-3	483-500	inter-hemispheric	_
3-4	501-513	connectivity	_
3-5	514-516	in	_
3-6	517-530	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-7	531-539	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-8	540-548	compared	_
3-9	549-551	to	_
3-10	552-560	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-11	561-566	using	_
3-12	567-581	voxel-mirrored	_
3-13	582-591	homotopic	_
3-14	592-604	connectivity	_
3-15	605-606	.	_

4-1	607-609	In	_
4-2	610-614	this	_
4-3	615-620	study	_
4-4	621-622	,	_
4-5	623-625	we	_
4-6	626-631	merge	_
4-7	632-637	these	_
4-8	638-641	two	_
4-9	642-648	points	_
4-10	649-651	of	_
4-11	652-657	views	_
4-12	658-666	together	_
4-13	667-672	using	_
4-14	673-674	a	_
4-15	675-680	group	_
4-16	681-692	independent	_
4-17	693-702	component	_
4-18	703-711	analysis	_
4-19	712-713	(	_
4-20	714-718	gICA	_
4-21	719-720	)	_
4-22	721-727	-based	_
4-23	728-736	approach	_
4-24	737-739	to	_
4-25	740-748	generate	_
4-26	749-768	hemisphere-specific	_
4-27	769-780	timecourses	_
4-28	781-784	and	_
4-29	785-794	calculate	_
4-30	795-811	intra-hemisphere	_
4-31	812-815	and	_
4-32	816-832	inter-hemisphere	_
4-33	833-836	FNC	_
4-34	837-839	on	_
4-35	840-841	a	_
4-36	842-849	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
4-37	850-855	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
4-38	856-860	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
4-39	861-868	dataset	_
4-40	869-879	consisting	_
4-41	880-882	of	_
4-42	883-887	age-	_
4-43	888-891	and	_
4-44	892-907	gender-balanced	_
4-45	908-911	151	_
4-46	912-925	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-47	926-934	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-48	935-938	and	_
4-49	939-942	163	_
4-50	943-950	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-51	951-959	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-52	960-961	.	_

5-1	962-964	We	_
5-2	965-973	analyzed	_
5-3	974-977	the	_
5-4	978-983	group	_
5-5	984-995	differences	_
5-6	996-1003	between	_
5-7	1004-1012	patients	_
5-8	1013-1016	and	_
5-9	1017-1024	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-10	1025-1033	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-11	1034-1036	in	_
5-12	1037-1041	each	_
5-13	1042-1046	type	_
5-14	1047-1049	of	_
5-15	1050-1053	FNC	_
5-16	1054-1062	measures	_
5-17	1063-1068	along	_
5-18	1069-1073	with	_
5-19	1074-1077	age	_
5-20	1078-1081	and	_
5-21	1082-1088	gender	_
5-22	1089-1096	effects	_
5-23	1097-1098	.	_

6-1	1099-1102	The	_
6-2	1103-1110	results	_
6-3	1111-1117	reveal	_
6-4	1118-1122	that	_
6-5	1123-1126	FNC	http://maven.renci.org/NeuroBridge/neurobridge#Thing
6-6	1127-1129	in	_
6-7	1130-1143	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-8	1144-1152	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-9	1153-1158	shows	_
6-10	1159-1163	less	_
6-11	1164-1175	hemispheric	_
6-12	1176-1185	asymmetry	_
6-13	1186-1194	compared	_
6-14	1195-1197	to	_
6-15	1198-1202	that	_
6-16	1203-1205	of	_
6-17	1206-1209	the	_
6-18	1210-1217	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
6-19	1218-1226	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
6-20	1227-1228	.	_

7-1	1229-1231	We	_
7-2	1232-1236	also	_
7-3	1237-1242	found	_
7-4	1243-1244	a	_
7-5	1245-1253	decrease	_
7-6	1254-1256	in	_
7-7	1257-1269	connectivity	_
7-8	1270-1272	in	_
7-9	1273-1276	all	_
7-10	1277-1280	FNC	_
7-11	1281-1286	types	_
7-12	1287-1291	such	_
7-13	1292-1294	as	_
7-14	1295-1305	intra-left	_
7-15	1306-1307	(	_
7-16	1308-1313	L_FNC	_
7-17	1314-1315	)	_
7-18	1316-1317	,	_
7-19	1318-1329	intra-right	_
7-20	1330-1331	(	_
7-21	1332-1337	R_FNC	_
7-22	1338-1339	)	_
7-23	1340-1343	and	_
7-24	1344-1360	inter-hemisphere	_
7-25	1361-1362	(	_
7-26	1363-1372	Inter_FNC	_
7-27	1373-1374	)	_
7-28	1375-1377	in	_
7-29	1378-1381	the	_
7-30	1382-1395	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
7-31	1396-1404	patients	_
7-32	1405-1413	relative	_
7-33	1414-1416	to	_
7-34	1417-1424	healthy	_
7-35	1425-1433	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
7-36	1434-1435	,	_
7-37	1436-1439	but	_
7-38	1440-1447	general	_
7-39	1448-1456	patterns	_
7-40	1457-1459	of	_
7-41	1460-1472	connectivity	_
7-42	1473-1477	were	_
7-43	1478-1487	preserved	_
7-44	1488-1490	in	_
7-45	1491-1499	patients	_
7-46	1500-1501	.	_

8-1	1502-1510	Analyses	_
8-2	1511-1513	of	_
8-3	1514-1517	age	_
8-4	1518-1521	and	_
8-5	1522-1528	gender	_
8-6	1529-1536	effects	_
8-7	1537-1544	yielded	_
8-8	1545-1552	results	_
8-9	1553-1560	similar	_
8-10	1561-1563	to	_
8-11	1564-1569	those	_
8-12	1570-1578	reported	_
8-13	1579-1581	in	_
8-14	1582-1587	whole	_
8-15	1588-1593	brain	_
8-16	1594-1597	FNC	_
8-17	1598-1605	studies	_
8-18	1606-1607	.	_

9-1	1608-1615	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
9-2	1616-1619	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
9-3	1620-1629	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
9-4	1630-1642	Participants	_
9-5	1643-1645	In	_
9-6	1646-1650	this	_
9-7	1651-1656	study	_
9-8	1657-1658	,	_
9-9	1659-1661	we	_
9-10	1662-1666	used	_
9-11	1667-1668	a	_
9-12	1669-1674	large	_
9-13	1675-1682	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
9-14	1683-1688	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
9-15	1689-1693	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
9-16	1694-1701	dataset	_
9-17	1702-1712	containing	_
9-18	1713-1716	314	_
9-19	1717-1725	subjects	_
9-20	1726-1727	,	_
9-21	1728-1731	163	_
9-22	1732-1739	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
9-23	1740-1748	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
9-24	1749-1750	(	_
9-25	1751-1754	117	_
9-26	1755-1760	males	_
9-27	1761-1762	,	_
9-28	1763-1765	46	_
9-29	1766-1773	females	_
9-30	1774-1775	;	_
9-31	1776-1780	mean	_
9-32	1781-1784	age	_
9-33	1785-1789	36.9	_
9-34	1790-1791	)	_
9-35	1792-1795	and	_
9-36	1796-1799	151	_
9-37	1800-1813	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-38	1814-1822	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-39	1823-1827	that	_
9-40	1828-1831	are	_
9-41	1832-1839	matched	_
9-42	1840-1842	in	_
9-43	1843-1846	age	_
9-44	1847-1850	and	_
9-45	1851-1857	gender	_
9-46	1858-1860	to	_
9-47	1861-1862	a	_
9-48	1863-1870	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
9-49	1871-1878	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
9-50	1879-1884	group	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
9-51	1885-1886	(	_
9-52	1887-1890	114	_
9-53	1891-1896	males	_
9-54	1897-1898	,	_
9-55	1899-1901	37	_
9-56	1902-1909	females	_
9-57	1910-1911	;	_
9-58	1912-1916	mean	_
9-59	1917-1920	age	_
9-60	1921-1925	37.8	_
9-61	1926-1927	)	_
9-62	1928-1936	combined	_
9-63	1937-1941	from	_
9-64	1942-1947	seven	_
9-65	1948-1957	different	_
9-66	1958-1963	sites	_
9-67	1964-1970	across	_
9-68	1971-1974	the	_
9-69	1975-1981	United	_
9-70	1982-1988	States	_
9-71	1989-1990	(	_
9-72	1991-1994	see	_
9-73	1995-2000	Table	_
9-74	2001-2002	1	_
9-75	2003-2004	)	_
9-76	2005-2008	and	_
9-77	2009-2015	passed	_
9-78	2016-2019	the	_
9-79	2020-2024	data	_
9-80	2025-2032	quality	_
9-81	2033-2040	control	_
9-82	2041-2042	.	_

10-1	2043-2051	Informed	_
10-2	2052-2059	consent	_
10-3	2060-2063	was	_
10-4	2064-2072	received	_
10-5	2073-2077	from	_
10-6	2078-2082	each	_
10-7	2083-2090	subject	_
10-8	2091-2096	prior	_
10-9	2097-2099	to	_
10-10	2100-2108	scanning	_
10-11	2109-2111	in	_
10-12	2112-2122	accordance	_
10-13	2123-2127	with	_
10-14	2128-2131	the	_
10-15	2132-2140	Internal	_
10-16	2141-2147	Review	_
10-17	2148-2154	Boards	_
10-18	2155-2157	of	_
10-19	2158-2171	corresponding	_
10-20	2172-2184	institutions	_
10-21	2185-2186	.	_

11-1	2187-2196	Cognitive	_
11-2	2197-2200	and	_
11-3	2201-2209	clinical	_
11-4	2210-2218	measures	_
11-5	2219-2223	were	_
11-6	2224-2233	collected	_
11-7	2234-2237	for	_
11-8	2238-2241	275	_
11-9	2242-2245	out	_
11-10	2246-2248	of	_
11-11	2249-2252	314	_
11-12	2253-2261	subjects	_
11-13	2262-2265	and	_
11-14	2266-2274	analyzed	_
11-15	2275-2277	as	_
11-16	2278-2290	Computerized	_
11-17	2291-2302	Multiphasic	_
11-18	2303-2314	Interactive	_
11-19	2315-2329	Neurocognitive	http://maven.renci.org/NeuroBridge/neurobridge#NeurocognitiveFunctionQuestionnaire
11-20	2330-2336	System	_
11-21	2337-2338	(	_
11-22	2339-2345	CMINDS	_
11-23	2346-2347	)	_
11-24	2348-2357	composite	_
11-25	2358-2364	scores	_
11-26	2365-2366	.	_

12-1	2367-2370	The	_
12-2	2371-2380	composite	_
12-3	2381-2387	scores	_
12-4	2388-2389	(	_
12-5	2390-2393	see	_
12-6	2394-2399	Table	_
12-7	2400-2401	2	_
12-8	2402-2403	)	_
12-9	2404-2413	summarize	_
12-10	2414-2417	the	_
12-11	2418-2425	overall	_
12-12	2426-2435	cognition	_
12-13	2436-2438	in	_
12-14	2439-2442	six	_
12-15	2443-2452	different	_
12-16	2453-2461	measures	_
12-17	2462-2463	:	_
12-18	2464-2483	attention/vigilance	_
12-19	2484-2485	,	_
12-20	2486-2491	speed	_
12-21	2492-2494	of	_
12-22	2495-2505	processing	_
12-23	2506-2507	,	_
12-24	2508-2514	verbal	_
12-25	2515-2523	learning	_
12-26	2524-2525	,	_
12-27	2526-2533	working	_
12-28	2534-2540	memory	_
12-29	2541-2542	,	_
12-30	2543-2549	visual	_
12-31	2550-2558	learning	_
12-32	2559-2562	and	_
12-33	2563-2580	reasoning/problem	_
12-34	2581-2588	solving	_
12-35	2589-2590	.	_

13-1	2591-2599	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-2	2600-2603	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-3	2604-2612	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-4	2613-2621	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-5	2622-2627	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-6	2628-2629	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-7	2630-2635	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-8	2636-2637	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
13-9	2638-2642	were	_
13-10	2643-2652	available	_
13-11	2653-2656	for	_
13-12	2657-2660	148	_
13-13	2661-2664	out	_
13-14	2665-2667	of	_
13-15	2668-2671	151	_
13-16	2672-2680	patients	_
13-17	2681-2684	and	_
13-18	2685-2698	antipsychotic	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder
13-19	2699-2713	chlorpromazine	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder
13-20	2714-2715	(	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder
13-21	2716-2719	CPZ	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder
13-22	2720-2721	)	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder
13-23	2722-2726	dose	_
13-24	2727-2738	equivalents	_
13-25	2739-2743	were	_
13-26	2744-2753	available	_
13-27	2754-2757	for	_
13-28	2758-2761	129	_
13-29	2762-2770	patients	_
13-30	2771-2772	(	_
13-31	2773-2776	112	_
13-32	2777-2785	subjects	_
13-33	2786-2790	were	_
13-34	2791-2798	treated	_
13-35	2799-2803	with	_
13-36	2804-2807	the	_
13-37	2808-2825	second-generation	_
13-38	2826-2828	or	_
13-39	2829-2837	atypical	_
13-40	2838-2848	medication	_
13-41	2849-2850	,	_
13-42	2851-2856	while	_
13-43	2857-2859	17	_
13-44	2860-2868	subjects	_
13-45	2869-2873	were	_
13-46	2874-2881	treated	_
13-47	2882-2886	with	_
13-48	2887-2903	first-generation	_
13-49	2904-2911	typical	_
13-50	2912-2925	antipsychotic	_
13-51	2926-2937	medications	_
13-52	2938-2939	.	_

14-1	2940-2951	Forty-eight	_
14-2	2952-2960	patients	_
14-3	2961-2965	were	_
14-4	2966-2970	also	_
14-5	2971-2978	treated	_
14-6	2979-2983	with	_
14-7	2984-2999	antidepressants	_
14-8	3000-3001	,	_
14-9	3002-3004	24	_
14-10	3005-3009	with	_
14-11	3010-3014	mood	_
14-12	3015-3026	stabilizers	_
14-13	3027-3028	,	_
14-14	3029-3032	and	_
14-15	3033-3035	18	_
14-16	3036-3040	with	_
14-17	3041-3060	anti-extrapyramidal	_
14-18	3061-3069	symptoms	_
14-19	3070-3080	medication	_
14-20	3081-3082	(	_
14-21	3083-3086	see	_
14-22	3087-3092	Table	_
14-23	3093-3094	3	_
14-24	3095-3096	)	_
14-25	3097-3098	.	_

15-1	3099-3103	Data	_
15-2	3104-3115	Acquisition	_
15-3	3116-3119	Six	_
15-4	3120-3122	of	_
15-5	3123-3126	the	_
15-6	3127-3132	seven	_
15-7	3133-3138	sites	_
15-8	3139-3148	collected	_
15-9	3149-3156	imaging	_
15-10	3157-3161	data	_
15-11	3162-3167	using	_
15-12	3168-3169	a	_
15-13	3170-3172	3T	_
15-14	3173-3180	Siemens	_
15-15	3181-3184	Tim	_
15-16	3185-3189	Trio	_
15-17	3190-3196	System	_
15-18	3197-3200	and	_
15-19	3201-3204	one	_
15-20	3205-3209	site	_
15-21	3210-3219	collected	_
15-22	3220-3227	imaging	_
15-23	3228-3232	data	_
15-24	3233-3235	on	_
15-25	3236-3237	a	_
15-26	3238-3240	3T	_
15-27	3241-3248	General	_
15-28	3249-3257	Electric	_
15-29	3258-3267	Discovery	_
15-30	3268-3273	MR750	_
15-31	3274-3281	scanner	_
15-32	3282-3283	.	_

16-1	3284-3291	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
16-2	3292-3297	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
16-3	3298-3302	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
16-4	3303-3308	scans	_
16-5	3309-3313	were	_
16-6	3314-3322	acquired	_
16-7	3323-3328	using	_
16-8	3329-3330	a	_
16-9	3331-3339	standard	_
16-10	3340-3353	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
16-11	3354-3358	echo	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
16-12	3359-3365	planar	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
16-13	3366-3373	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
16-14	3374-3382	paradigm	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
16-15	3383-3384	:	_
16-16	3385-3388	FOV	_
16-17	3389-3391	of	_
16-18	3392-3395	220	_
16-19	3396-3397	×	_
16-20	3398-3401	220	_
16-21	3402-3404	mm	_
16-22	3405-3406	(	_
16-23	3407-3409	64	_
16-24	3410-3411	×	_
16-25	3412-3414	64	_
16-26	3415-3421	matrix	_
16-27	3422-3423	)	_
16-28	3424-3425	,	_
16-29	3426-3430	TR=2	_
16-30	3431-3432	s	_
16-31	3433-3434	,	_
16-32	3435-3440	TE=30	_
16-33	3441-3443	ms	_
16-34	3444-3445	,	_
16-35	3446-3452	FA=770	_
16-36	3453-3454	,	_
16-37	3455-3458	162	_
16-38	3459-3466	volumes	_
16-39	3467-3468	,	_
16-40	3469-3477	duration	_
16-41	3478-3480	of	_
16-42	3481-3482	5	_
16-43	3483-3490	minutes	_
16-44	3491-3494	and	_
16-45	3495-3497	24	_
16-46	3498-3505	seconds	_
16-47	3506-3507	,	_
16-48	3508-3510	32	_
16-49	3511-3521	sequential	_
16-50	3522-3531	ascending	_
16-51	3532-3537	axial	_
16-52	3538-3544	slices	_
16-53	3545-3547	of	_
16-54	3548-3549	4	_
16-55	3550-3552	mm	_
16-56	3553-3562	thickness	_
16-57	3563-3566	and	_
16-58	3567-3568	1	_
16-59	3569-3571	mm	_
16-60	3572-3575	gap	_
16-61	3576-3577	.	_

17-1	3578-3586	Subjects	_
17-2	3587-3591	were	_
17-3	3592-3602	instructed	_
17-4	3603-3605	to	_
17-5	3606-3611	close	_
17-6	3612-3617	their	_
17-7	3618-3622	eyes	_
17-8	3623-3626	and	_
17-9	3627-3631	stay	_
17-10	3632-3637	awake	_
17-11	3638-3644	during	_
17-12	3645-3648	the	_
17-13	3649-3656	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
17-14	3657-3662	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
17-15	3663-3667	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
17-16	3668-3669	.	_

18-1	3670-3683	Preprocessing	_
18-2	3684-3694	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
18-3	3695-3698	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
18-4	3699-3703	data	_
18-5	3704-3708	were	_
18-6	3709-3721	preprocessed	_
18-7	3722-3726	with	_
18-8	3727-3730	the	_
18-9	3731-3739	pipeline	_
18-10	3740-3749	described	_
18-11	3750-3752	in	_
18-12	3753-3754	,	_
18-13	3755-3760	using	_
18-14	3761-3762	a	_
18-15	3763-3774	combination	_
18-16	3775-3777	of	_
18-17	3778-3787	toolboxes	_
18-18	3788-3792	such	_
18-19	3793-3795	as	_
18-20	3796-3800	AFNI	_
18-21	3801-3802	(	_
18-22	3803-3808	https	_
18-23	3809-3810	:	_
18-24	3811-3830	//afni.nimh.nih.gov	_
18-25	3831-3832	)	_
18-26	3833-3834	,	_
18-27	3835-3838	SPM	_
18-28	3839-3840	(	_
18-29	3841-3845	http	_
18-30	3846-3847	:	_
18-31	3848-3875	//www.fil.ion.ucl.ac.uk/spm	_
18-32	3876-3877	)	_
18-33	3878-3879	,	_
18-34	3880-3884	GIFT	_
18-35	3885-3886	(	_
18-36	3887-3891	http	_
18-37	3892-3893	:	_
18-38	3894-3922	mialab.mrn.org/software/gift	_
18-39	3923-3924	)	_
18-40	3925-3928	and	_
18-41	3929-3935	MATLAB	_
18-42	3936-3937	.	_

19-1	3938-3941	The	_
19-2	3942-3951	INRIAlign	_
19-3	3952-3959	toolbox	_
19-4	3960-3962	in	_
19-5	3963-3966	SPM	_
19-6	3967-3970	was	_
19-7	3971-3975	used	_
19-8	3976-3979	for	_
19-9	3980-3985	rigid	_
19-10	3986-3990	body	_
19-11	3991-3997	motion	_
19-12	3998-4008	correction	_
19-13	4009-4012	for	_
19-14	4013-4020	subject	_
19-15	4021-4025	head	_
19-16	4026-4032	motion	_
19-17	4033-4041	followed	_
19-18	4042-4044	by	_
19-19	4045-4057	slice-timing	_
19-20	4058-4068	correction	_
19-21	4069-4071	to	_
19-22	4072-4079	account	_
19-23	4080-4083	for	_
19-24	4084-4090	timing	_
19-25	4091-4102	differences	_
19-26	4103-4105	in	_
19-27	4106-4111	slice	_
19-28	4112-4123	acquisition	_
19-29	4124-4125	.	_

20-1	4126-4129	The	_
20-2	4130-4132	3D	_
20-3	4133-4140	Despike	_
20-4	4141-4150	algorithm	_
20-5	4151-4153	in	_
20-6	4154-4158	AFNI	_
20-7	4159-4162	was	_
20-8	4163-4167	used	_
20-9	4168-4170	to	_
20-10	4171-4177	remove	_
20-11	4178-4183	spike	_
20-12	4184-4193	artifacts	_
20-13	4194-4198	from	_
20-14	4199-4202	the	_
20-15	4203-4207	fMRI	_
20-16	4208-4212	data	_
20-17	4213-4214	.	_

21-1	4215-4218	The	_
21-2	4219-4223	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
21-3	4224-4228	data	_
21-4	4229-4233	were	_
21-5	4234-4240	warped	_
21-6	4241-4243	to	_
21-7	4244-4245	a	_
21-8	4246-4254	Montreal	_
21-9	4255-4267	Neurological	_
21-10	4268-4277	Institute	_
21-11	4278-4279	(	_
21-12	4280-4283	MNI	_
21-13	4284-4285	)	_
21-14	4286-4294	template	_
21-15	4295-4296	,	_
21-16	4297-4306	resampled	_
21-17	4307-4309	to	_
21-18	4310-4311	3	_
21-19	4312-4315	mm3	_
21-20	4316-4325	isotropic	_
21-21	4326-4332	voxels	_
21-22	4333-4334	,	_
21-23	4335-4338	and	_
21-24	4339-4347	smoothed	_
21-25	4348-4352	with	_
21-26	4353-4354	a	_
21-27	4355-4356	6	_
21-28	4357-4359	mm	_
21-29	4360-4364	full	_
21-30	4365-4370	width	_
21-31	4371-4373	at	_
21-32	4374-4378	half	_
21-33	4379-4386	maximum	_
21-34	4387-4388	(	_
21-35	4389-4393	FWHM	_
21-36	4394-4395	)	_
21-37	4396-4401	using	_
21-38	4402-4406	AFNI	_
21-39	4407-4408	.	_

22-1	4409-4413	Each	_
22-2	4414-4419	voxel	_
22-3	4420-4430	timecourse	_
22-4	4431-4434	was	_
22-5	4435-4443	variance	_
22-6	4444-4454	normalized	_
22-7	4455-4460	prior	_
22-8	4461-4463	to	_
22-9	4464-4467	the	_
22-10	4468-4472	gICA	_
22-11	4473-4474	;	_
22-12	4475-4478	for	_
22-13	4479-4489	additional	_
22-14	4490-4495	image	_
22-15	4496-4509	preprocessing	_
22-16	4510-4517	details	_
22-17	4518-4519	,	_
22-18	4520-4523	see	_
22-19	4524-4525	a	_
22-20	4526-4534	previous	_
22-21	4535-4540	study	_
22-22	4541-4542	.	_

23-1	4543-4548	Group	_
23-2	4549-4560	Independent	_
23-3	4561-4570	Component	_
23-4	4571-4579	Analysis	_
23-5	4580-4583	The	_
23-6	4584-4596	preprocessed	_
23-7	4597-4601	data	_
23-8	4602-4605	was	_
23-9	4606-4616	decomposed	_
23-10	4617-4621	into	_
23-11	4622-4625	100	_
23-12	4626-4635	spatially	_
23-13	4636-4647	independent	_
23-14	4648-4658	components	_
23-15	4659-4664	using	_
23-16	4665-4669	gICA	_
23-17	4670-4681	implemented	_
23-18	4682-4684	in	_
23-19	4685-4689	GIFT	_
23-20	4690-4691	.	_

24-1	4692-4695	The	_
24-2	4696-4700	gICA	_
24-3	4701-4711	identifies	_
24-4	4712-4721	spatially	_
24-5	4722-4730	distinct	_
24-6	4731-4732	,	_
24-7	4733-4754	functionally-coherent	_
24-8	4755-4763	networks	_
24-9	4764-4766	by	_
24-10	4767-4777	estimating	_
24-11	4778-4787	maximally	_
24-12	4788-4799	independent	_
24-13	4800-4807	spatial	_
24-14	4808-4815	sources	_
24-15	4816-4817	(	_
24-16	4818-4820	or	_
24-17	4821-4828	spatial	_
24-18	4829-4833	maps	_
24-19	4834-4835	)	_
24-20	4836-4840	from	_
24-21	4841-4846	their	_
24-22	4847-4861	linearly-mixed	_
24-23	4862-4866	fMRI	_
24-24	4867-4874	signals	_
24-25	4875-4877	or	_
24-26	4878-4889	timecourses	_
24-27	4890-4891	.	_

25-1	4892-4895	Out	_
25-2	4896-4898	of	_
25-3	4899-4902	the	_
25-4	4903-4911	original	_
25-5	4912-4915	100	_
25-6	4916-4926	components	_
25-7	4927-4928	,	_
25-8	4929-4931	47	_
25-9	4932-4942	components	_
25-10	4943-4947	were	_
25-11	4948-4958	identified	_
25-12	4959-4961	as	_
25-13	4962-4969	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-14	4970-4975	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-15	4976-4984	networks	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-16	4985-4986	(	_
25-17	4987-4991	RSNs	_
25-18	4992-4993	)	_
25-19	4994-4999	based	_
25-20	5000-5002	on	_
25-21	5003-5010	several	_
25-22	5011-5019	criteria	_
25-23	5020-5021	:	_
25-24	5022-5031	maximally	_
25-25	5032-5041	activated	_
25-26	5042-5048	voxels	_
25-27	5049-5056	located	_
25-28	5057-5059	in	_
25-29	5060-5070	identified	_
25-30	5071-5075	gray	_
25-31	5076-5082	matter	_
25-32	5083-5084	,	_
25-33	5085-5092	minimal	_
25-34	5093-5100	spatial	_
25-35	5101-5108	overlap	_
25-36	5109-5113	with	_
25-37	5114-5119	known	_
25-38	5120-5128	vascular	_
25-39	5129-5130	,	_
25-40	5131-5142	ventricular	_
25-41	5143-5146	and	_
25-42	5147-5158	head-motion	_
25-43	5159-5170	susceptible	_
25-44	5171-5175	edge	_
25-45	5176-5183	regions	_
25-46	5184-5187	and	_
25-47	5188-5196	combined	_
25-48	5197-5201	with	_
25-49	5202-5207	large	_
25-50	5208-5219	low-to-high	_
25-51	5220-5229	frequency	_
25-52	5230-5238	spectral	_
25-53	5239-5244	power	_
25-54	5245-5251	ratios	_
25-55	5252-5254	in	_
25-56	5255-5258	the	_
25-57	5259-5268	component	_
25-58	5269-5280	timecourses	_
25-59	5281-5282	.	_

26-1	5283-5285	We	_
26-2	5286-5291	refer	_
26-3	5292-5295	the	_
26-4	5296-5303	readers	_
26-5	5304-5306	to	_
26-6	5307-5315	previous	_
26-7	5316-5324	research	_
26-8	5325-5328	for	_
26-9	5329-5330	a	_
26-10	5331-5339	detailed	_
26-11	5340-5350	discussion	_
26-12	5351-5353	of	_
26-13	5354-5357	the	_
26-14	5358-5362	gICA	_
26-15	5363-5371	analysis	_
26-16	5372-5381	performed	_
26-17	5382-5384	on	_
26-18	5385-5389	this	_
26-19	5390-5394	data	_
26-20	5395-5398	and	_
26-21	5399-5408	selection	_
26-22	5409-5411	of	_
26-23	5412-5416	RSNs	_
26-24	5417-5418	.	_

27-1	5419-5429	Generating	_
27-2	5430-5439	Templates	_
27-3	5440-5443	and	_
27-4	5444-5463	Hemisphere-Specific	_
27-5	5464-5475	Timecourses	_
27-6	5476-5478	We	_
27-7	5479-5487	utilized	_
27-8	5488-5502	spatiotemporal	_
27-9	5503-5513	regression	_
27-10	5514-5516	on	_
27-11	5517-5528	symmetrized	_
27-12	5529-5539	aggregated	_
27-13	5540-5547	spatial	_
27-14	5548-5552	maps	_
27-15	5553-5555	of	_
27-16	5556-5559	the	_
27-17	5560-5570	components	_
27-18	5571-5573	to	_
27-19	5574-5582	generate	_
27-20	5583-5602	hemisphere-specific	_
27-21	5603-5612	component	_
27-22	5613-5624	timecourses	_
27-23	5625-5626	.	_

28-1	5627-5638	Symmetrized	_
28-2	5639-5649	aggregated	_
28-3	5650-5657	spatial	_
28-4	5658-5662	maps	_
28-5	5663-5667	were	_
28-6	5668-5677	generated	_
28-7	5678-5680	by	_
28-8	5681-5689	flipping	_
28-9	5690-5693	the	_
28-10	5694-5702	original	_
28-11	5703-5713	aggregated	_
28-12	5714-5721	spatial	_
28-13	5722-5726	maps	_
28-14	5727-5732	along	_
28-15	5733-5738	their	_
28-16	5739-5746	lateral	_
28-17	5747-5751	axes	_
28-18	5752-5755	and	_
28-19	5756-5758	by	_
28-20	5759-5763	then	_
28-21	5764-5773	comparing	_
28-22	5774-5778	each	_
28-23	5779-5786	flipped	_
28-24	5787-5792	voxel	_
28-25	5793-5798	value	_
28-26	5799-5803	with	_
28-27	5804-5807	its	_
28-28	5808-5817	unflipped	_
28-29	5818-5823	voxel	_
28-30	5824-5829	value	_
28-31	5830-5833	and	_
28-32	5834-5843	retaining	_
28-33	5844-5847	the	_
28-34	5848-5855	maximum	_
28-35	5856-5865	intensity	_
28-36	5866-5871	value	_
28-37	5872-5873	.	_

29-1	5874-5879	Hence	_
29-2	5880-5881	,	_
29-3	5882-5885	the	_
29-4	5886-5897	symmetrized	_
29-5	5898-5906	versions	_
29-6	5907-5909	of	_
29-7	5910-5913	the	_
29-8	5914-5924	components	_
29-9	5925-5929	that	_
29-10	5930-5933	are	_
29-11	5934-5940	mirror	_
29-12	5941-5947	images	_
29-13	5948-5950	of	_
29-14	5951-5955	each	_
29-15	5956-5961	other	_
29-16	5962-5966	will	_
29-17	5967-5969	be	_
29-18	5970-5979	collinear	_
29-19	5980-5981	(	_
29-20	5982-5986	e.g.	_
29-21	5987-5988	,	_
29-22	5989-5999	components	_
29-23	6000-6002	91	_
29-24	6003-6004	,	_
29-25	6005-6009	left	_
29-26	6010-6017	lingual	_
29-27	6018-6023	gyrus	_
29-28	6024-6027	and	_
29-29	6028-6030	76	_
29-30	6031-6032	,	_
29-31	6033-6038	right	_
29-32	6039-6046	lingual	_
29-33	6047-6052	gyrus	_
29-34	6053-6054	)	_
29-35	6055-6056	.	_

30-1	6057-6059	We	_
30-2	6060-6066	tested	_
30-3	6067-6079	collinearity	_
30-4	6080-6082	of	_
30-5	6083-6086	the	_
30-6	6087-6097	components	_
30-7	6098-6103	using	_
30-8	6104-6105	a	_
30-9	6106-6114	variance	_
30-10	6115-6124	inflation	_
30-11	6125-6131	factor	_
30-12	6132-6135	and	_
30-13	6136-6143	removed	_
30-14	6144-6148	four	_
30-15	6149-6153	RSNs	_
30-16	6154-6155	(	_
30-17	6156-6158	IC	_
30-18	6159-6160	6	_
30-19	6161-6162	,	_
30-20	6163-6165	91	_
30-21	6166-6167	,	_
30-22	6168-6170	66	_
30-23	6171-6174	and	_
30-24	6175-6177	84	_
30-25	6178-6179	)	_
30-26	6180-6184	from	_
30-27	6185-6188	our	_
30-28	6189-6197	analyses	_
30-29	6198-6199	,	_
30-30	6200-6205	which	_
30-31	6206-6209	had	_
30-32	6210-6214	high	_
30-33	6215-6227	collinearity	_
30-34	6228-6232	with	_
30-35	6233-6243	components	_
30-36	6244-6246	IC	_
30-37	6247-6249	10	_
30-38	6250-6251	(	_
30-39	6252-6262	precentral	_
30-40	6263-6266	and	_
30-41	6267-6278	postcentral	_
30-42	6279-6284	gyrus	_
30-43	6285-6286	)	_
30-44	6287-6288	,	_
30-45	6289-6291	IC	_
30-46	6292-6294	76	_
30-47	6295-6296	(	_
30-48	6297-6304	lingual	_
30-49	6305-6310	gyrus	_
30-50	6311-6312	)	_
30-51	6313-6314	,	_
30-52	6315-6317	IC	_
30-53	6318-6320	94	_
30-54	6321-6322	(	_
30-55	6323-6331	inferior	_
30-56	6332-6340	parietal	_
30-57	6341-6347	lobule	_
30-58	6348-6349	)	_
30-59	6350-6353	and	_
30-60	6354-6356	IC	_
30-61	6357-6359	95	_
30-62	6360-6361	(	_
30-63	6362-6369	angular	_
30-64	6370-6375	gyrus	_
30-65	6376-6377	)	_
30-66	6378-6390	respectively	_
30-67	6391-6392	.	_

31-1	6393-6395	We	_
31-2	6396-6400	also	_
31-3	6401-6408	removed	_
31-4	6409-6413	four	_
31-5	6414-6422	artifact	_
31-6	6423-6433	components	_
31-7	6434-6438	that	_
31-8	6439-6442	had	_
31-9	6443-6444	a	_
31-10	6445-6450	large	_
31-11	6451-6459	variance	_
31-12	6460-6469	inflation	_
31-13	6470-6476	factor	_
31-14	6477-6478	(	_
31-15	6479-6481	IC	_
31-16	6482-6484	17	_
31-17	6485-6486	,	_
31-18	6487-6489	31	_
31-19	6490-6492	39	_
31-20	6493-6496	and	_
31-21	6497-6499	52	_
31-22	6500-6501	)	_
31-23	6502-6503	.	_

32-1	6504-6509	After	_
32-2	6510-6518	removals	_
32-3	6519-6520	,	_
32-4	6521-6524	the	_
32-5	6525-6529	data	_
32-6	6530-6539	comprised	_
32-7	6540-6542	92	_
32-8	6543-6554	symmetrized	_
32-9	6555-6556	,	_
32-10	6557-6567	aggregated	_
32-11	6568-6575	spatial	_
32-12	6576-6580	maps	_
32-13	6581-6582	(	_
32-14	6583-6585	43	_
32-15	6586-6590	RSNs	_
32-16	6591-6592	&	_
32-17	6593-6595	49	_
32-18	6596-6605	artifacts	_
32-19	6606-6607	)	_
32-20	6608-6611	for	_
32-21	6612-6622	subsequent	_
32-22	6623-6631	analyses	_
32-23	6632-6633	.	_

33-1	6634-6638	Then	_
33-2	6639-6640	,	_
33-3	6641-6643	we	_
33-4	6644-6649	split	_
33-5	6650-6653	the	_
33-6	6654-6665	symmetrized	_
33-7	6666-6673	spatial	_
33-8	6674-6678	maps	_
33-9	6679-6682	and	_
33-10	6683-6695	preprocessed	_
33-11	6696-6703	subject	_
33-12	6704-6708	data	_
33-13	6709-6713	into	_
33-14	6714-6718	left	_
33-15	6719-6722	and	_
33-16	6723-6728	right	_
33-17	6729-6740	hemispheres	_
33-18	6741-6742	.	_

34-1	6743-6750	Finally	_
34-2	6751-6752	,	_
34-3	6753-6755	we	_
34-4	6756-6763	applied	_
34-5	6764-6778	spatiotemporal	_
34-6	6779-6789	regression	_
34-7	6790-6792	on	_
34-8	6793-6796	the	_
34-9	6797-6801	left	_
34-10	6802-6805	and	_
34-11	6806-6811	right	_
34-12	6812-6823	hemispheres	_
34-13	6824-6834	separately	_
34-14	6835-6837	to	_
34-15	6838-6846	generate	_
34-16	6847-6863	subject-specific	_
34-17	6864-6869	left-	_
34-18	6870-6873	and	_
34-19	6874-6890	right-hemisphere	_
34-20	6891-6902	timecourses	_
34-21	6903-6906	and	_
34-22	6907-6914	spatial	_
34-23	6915-6919	maps	_
34-24	6920-6925	using	_
34-25	6926-6930	GIFT	_
34-26	6931-6932	.	_

35-1	6933-6942	Generated	_
35-2	6943-6947	RSNs	_
35-3	6948-6951	are	_
35-4	6952-6961	displayed	_
35-5	6962-6964	in	_
35-6	6965-6971	Figure	_
35-7	6972-6973	1	_
35-8	6974-6976	in	_
35-9	6977-6982	terms	_
35-10	6983-6985	of	_
35-11	6986-6998	t-statistics	_
35-12	6999-7000	,	_
35-13	7001-7004	and	_
35-14	7005-7008	the	_
35-15	7009-7022	corresponding	_
35-16	7023-7026	MNI	_
35-17	7027-7034	regions	_
35-18	7035-7038	are	_
35-19	7039-7048	presented	_
35-20	7049-7051	in	_
35-21	7052-7057	Table	_
35-22	7058-7059	4	_
35-23	7060-7061	.	_

36-1	7062-7072	Functional	_
36-2	7073-7080	Network	_
36-3	7081-7093	Connectivity	_
36-4	7094-7105	Calculation	_
36-5	7106-7109	For	_
36-6	7110-7114	each	_
36-7	7115-7125	hemisphere	_
36-8	7126-7127	,	_
36-9	7128-7135	subject	_
36-10	7136-7147	timecourses	_
36-11	7148-7152	went	_
36-12	7153-7160	through	_
36-13	7161-7176	post-processing	_
36-14	7177-7182	steps	_
36-15	7183-7184	.	_

37-1	7185-7189	Time	_
37-2	7190-7196	series	_
37-3	7197-7199	of	_
37-4	7200-7204	RSNs	_
37-5	7205-7209	were	_
37-6	7210-7219	detrended	_
37-7	7220-7223	and	_
37-8	7224-7238	orthogonalized	_
37-9	7239-7243	with	_
37-10	7244-7251	respect	_
37-11	7252-7254	to	_
37-12	7255-7258	the	_
37-13	7259-7268	estimated	_
37-14	7269-7280	realignment	_
37-15	7281-7291	parameters	_
37-16	7292-7293	(	_
37-17	7294-7303	including	_
37-18	7304-7309	their	_
37-19	7310-7321	derivatives	_
37-20	7322-7325	and	_
37-21	7326-7331	their	_
37-22	7332-7339	squares	_
37-23	7340-7343	and	_
37-24	7344-7355	derivatives	_
37-25	7356-7358	of	_
37-26	7359-7364	their	_
37-27	7365-7372	squares	_
37-28	7373-7374	)	_
37-29	7375-7376	,	_
37-30	7377-7385	despiked	_
37-31	7386-7387	,	_
37-32	7388-7391	and	_
37-33	7392-7401	band-pass	_
37-34	7402-7410	filtered	_
37-35	7411-7416	using	_
37-36	7417-7418	a	_
37-37	7419-7430	fifth-order	_
37-38	7431-7442	Butterworth	_
37-39	7443-7449	filter	_
37-40	7450-7454	with	_
37-41	7455-7461	cutoff	_
37-42	7462-7473	frequencies	_
37-43	7474-7476	of	_
37-44	7477-7478	[	_
37-45	7479-7484	0.01-	_
37-46	7485-7489	0.15	_
37-47	7490-7492	Hz	_
37-48	7493-7494	]	_
37-49	7495-7496	.	_

38-1	7497-7500	The	_
38-2	7501-7504	FNC	_
38-3	7505-7512	between	_
38-4	7513-7516	the	_
38-5	7517-7520	two	_
38-6	7521-7531	components	_
38-7	7532-7534	is	_
38-8	7535-7545	calculated	_
38-9	7546-7548	by	_
38-10	7549-7554	using	_
38-11	7555-7556	a	_
38-12	7557-7563	cosine	_
38-13	7564-7574	similarity	_
38-14	7575-7582	measure	_
38-15	7583-7585	as	_
38-16	7586-7593	follows	_
38-17	7594-7595	:	_
38-18	7596-7599	The	_
38-19	7600-7604	TCCX	_
38-20	7605-7608	and	_
38-21	7609-7613	TCcy	_
38-22	7614-7617	are	_
38-23	7618-7621	the	_
38-24	7622-7633	timecourses	_
38-25	7634-7636	of	_
38-26	7637-7640	two	_
38-27	7641-7650	different	_
38-28	7651-7661	components	_
38-29	7662-7665	and	_
38-30	7666-7667	n	_
38-31	7668-7670	is	_
38-32	7671-7674	the	_
38-33	7675-7681	length	_
38-34	7682-7684	of	_
38-35	7685-7688	the	_
38-36	7689-7700	timecourses	_
38-37	7701-7702	.	_

39-1	7703-7706	The	_
39-2	7707-7710	FNC	_
39-3	7711-7719	matrices	_
39-4	7720-7723	are	_
39-5	7724-7734	calculated	_
39-6	7735-7740	using	_
39-7	7741-7744	the	_
39-8	7745-7756	timecourses	_
39-9	7757-7759	of	_
39-10	7760-7762	43	_
39-11	7763-7767	left	_
39-12	7768-7778	components	_
39-13	7779-7782	and	_
39-14	7783-7785	43	_
39-15	7786-7791	right	_
39-16	7792-7802	components	_
39-17	7803-7804	.	_

40-1	7805-7808	For	_
40-2	7809-7813	each	_
40-3	7814-7821	subject	_
40-4	7822-7823	,	_
40-5	7824-7826	we	_
40-6	7827-7831	have	_
40-7	7832-7834	an	_
40-8	7835-7845	intra-left	_
40-9	7846-7856	hemisphere	_
40-10	7857-7858	(	_
40-11	7859-7864	L_FNC	_
40-12	7865-7866	)	_
40-13	7867-7868	(	_
40-14	7869-7872	903	_
40-15	7873-7878	pairs	_
40-16	7879-7880	(	_
40-17	7881-7884	432	_
40-18	7885-7886	–	_
40-19	7887-7889	43	_
40-20	7890-7891	)	_
40-21	7892-7894	/2	_
40-22	7895-7896	)	_
40-23	7897-7898	,	_
40-24	7899-7901	an	_
40-25	7902-7913	intra-right	_
40-26	7914-7924	hemisphere	_
40-27	7925-7926	(	_
40-28	7927-7932	R_FNC	_
40-29	7933-7934	)	_
40-30	7935-7936	(	_
40-31	7937-7940	903	_
40-32	7941-7946	pairs	_
40-33	7947-7948	)	_
40-34	7949-7952	and	_
40-35	7953-7955	an	_
40-36	7956-7972	inter-hemisphere	_
40-37	7973-7974	(	_
40-38	7975-7984	Inter_FNC	_
40-39	7985-7986	)	_
40-40	7987-7988	(	_
40-41	7989-7993	1849	_
40-42	7994-7999	pairs	_
40-43	8000-8004	with	_
40-44	8005-8007	43	_
40-45	8008-8017	homotopic	_
40-46	8018-8023	pairs	_
40-47	8024-8025	(	_
40-48	8026-8029	432	_
40-49	8030-8031	)	_
40-50	8032-8033	)	_
40-51	8034-8037	FNC	_
40-52	8038-8046	matrices	_
40-53	8047-8048	.	_

41-1	8049-8060	Calculating	_
41-2	8061-8066	Group	_
41-3	8067-8075	Averages	_
41-4	8076-8080	Both	_
41-5	8081-8086	using	_
41-6	8087-8090	all	_
41-7	8091-8103	participants	_
41-8	8104-8107	and	_
41-9	8108-8112	also	_
41-10	8113-8117	used	_
41-11	8118-8128	separately	_
41-12	8129-8132	for	_
41-13	8133-8136	the	_
41-14	8137-8144	patient	_
41-15	8145-8148	and	_
41-16	8149-8156	control	_
41-17	8157-8166	subgroups	_
41-18	8167-8168	,	_
41-19	8169-8171	we	_
41-20	8172-8178	tested	_
41-21	8179-8186	whether	_
41-22	8187-8190	the	_
41-23	8191-8194	FNC	_
41-24	8195-8200	means	_
41-25	8201-8207	differ	_
41-26	8208-8212	from	_
41-27	8213-8217	zero	_
41-28	8218-8220	by	_
41-29	8221-8226	using	_
41-30	8227-8230	one	_
41-31	8231-8237	sample	_
41-32	8238-8244	t-test	_
41-33	8245-8249	with	_
41-34	8250-8251	a	_
41-35	8252-8256	0.05	_
41-36	8257-8262	false	_
41-37	8263-8272	discovery	_
41-38	8273-8277	rate	_
41-39	8278-8279	(	_
41-40	8280-8283	FDR	_
41-41	8284-8285	)	_
41-42	8286-8296	correction	_
41-43	8297-8298	.	_

42-1	8299-8305	Figure	_
42-2	8306-8307	2	_
42-3	8308-8313	shows	_
42-4	8314-8317	the	_
42-5	8318-8325	results	_
42-6	8326-8329	for	_
42-7	8330-8334	each	_
42-8	8335-8337	of	_
42-9	8338-8341	the	_
42-10	8342-8346	FNCs	_
42-11	8347-8349	of	_
42-12	8350-8357	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
42-13	8358-8365	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
42-14	8366-8369	and	_
42-15	8370-8383	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
42-16	8384-8392	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
42-17	8393-8394	.	_

43-1	8395-8398	For	_
43-2	8399-8412	visualization	_
43-3	8413-8421	purposes	_
43-4	8422-8423	,	_
43-5	8424-8426	we	_
43-6	8427-8436	displayed	_
43-7	8437-8446	homotopic	_
43-8	8447-8450	FNC	_
43-9	8451-8458	results	_
43-10	8459-8461	in	_
43-11	8462-8463	a	_
43-12	8464-8467	bar	_
43-13	8468-8472	plot	_
43-14	8473-8474	.	_

44-1	8475-8484	Comparing	_
44-2	8485-8493	Strength	_
44-3	8494-8496	of	_
44-4	8497-8508	lateralized	_
44-5	8509-8512	FNC	_
44-6	8513-8518	types	_
44-7	8519-8521	in	_
44-8	8522-8530	Patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
44-9	8531-8534	and	_
44-10	8535-8542	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
44-11	8543-8550	Control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
44-12	8551-8554	For	_
44-13	8555-8558	the	_
44-14	8559-8566	patient	_
44-15	8567-8570	and	_
44-16	8571-8578	healthy	_
44-17	8579-8586	control	_
44-18	8587-8596	subgroups	_
44-19	8597-8598	,	_
44-20	8599-8601	we	_
44-21	8602-8610	compared	_
44-22	8611-8614	the	_
44-23	8615-8623	strength	_
44-24	8624-8626	of	_
44-25	8627-8639	connectivity	_
44-26	8640-8648	captured	_
44-27	8649-8651	in	_
44-28	8652-8657	L_FNC	_
44-29	8658-8659	,	_
44-30	8660-8665	R_FNC	_
44-31	8666-8667	,	_
44-32	8668-8671	and	_
44-33	8672-8674	in	_
44-34	8675-8684	Inter_FNC	_
44-35	8685-8686	.	_

45-1	8687-8696	Inter_FNC	_
45-2	8697-8698	’	_
45-3	8699-8700	s	_
45-4	8701-8706	upper	_
45-5	8707-8717	triangular	_
45-6	8718-8719	(	_
45-7	8720-8726	RL_FNC	_
45-8	8727-8728	)	_
45-9	8729-8732	and	_
45-10	8733-8738	lower	_
45-11	8739-8749	triangular	_
45-12	8750-8751	(	_
45-13	8752-8758	LR_FNC	_
45-14	8759-8760	)	_
45-15	8761-8766	parts	_
45-16	8767-8771	were	_
45-17	8772-8777	taken	_
45-18	8778-8788	separately	_
45-19	8789-8792	for	_
45-20	8793-8803	comparison	_
45-21	8804-8805	.	_

46-1	8806-8808	To	_
46-2	8809-8811	do	_
46-3	8812-8814	so	_
46-4	8815-8818	for	_
46-5	8819-8823	each	_
46-6	8824-8829	group	_
46-7	8830-8833	and	_
46-8	8834-8837	for	_
46-9	8838-8842	each	_
46-10	8843-8847	type	_
46-11	8848-8850	of	_
46-12	8851-8854	FNC	_
46-13	8855-8856	,	_
46-14	8857-8859	we	_
46-15	8860-8865	first	_
46-16	8866-8875	regressed	_
46-17	8876-8879	out	_
46-18	8880-8886	motion	_
46-19	8887-8889	as	_
46-20	8890-8894	mean	_
46-21	8895-8900	frame	_
46-22	8901-8913	displacement	_
46-23	8914-8917	and	_
46-24	8918-8922	site	_
46-25	8923-8925	ID	_
46-26	8926-8927	.	_

47-1	8928-8933	Later	_
47-2	8934-8935	,	_
47-3	8936-8938	we	_
47-4	8939-8948	performed	_
47-5	8949-8950	a	_
47-6	8951-8954	one	_
47-7	8955-8961	sample	_
47-8	8962-8968	t-test	_
47-9	8969-8971	in	_
47-10	8972-8976	each	_
47-11	8977-8982	group	_
47-12	8983-8993	separately	_
47-13	8994-8997	and	_
47-14	8998-9009	thresholded	_
47-15	9010-9014	with	_
47-16	9015-9019	0.05	_
47-17	9020-9026	levels	_
47-18	9027-9030	FDR	_
47-19	9031-9041	correction	_
47-20	9042-9043	,	_
47-21	9044-9047	and	_
47-22	9048-9052	then	_
47-23	9053-9061	retained	_
47-24	9062-9065	the	_
47-25	9066-9069	FNC	_
47-26	9070-9077	indices	_
47-27	9078-9082	that	_
47-28	9083-9087	were	_
47-29	9088-9101	significantly	_
47-30	9102-9111	different	_
47-31	9112-9116	from	_
47-32	9117-9118	0	_
47-33	9119-9120	.	_

48-1	9121-9125	Then	_
48-2	9126-9129	for	_
48-3	9130-9134	each	_
48-4	9135-9139	pair	_
48-5	9140-9142	of	_
48-6	9143-9151	compared	_
48-7	9152-9155	FNC	_
48-8	9156-9161	types	_
48-9	9162-9163	(	_
48-10	9164-9168	FNCs	_
48-11	9169-9173	that	_
48-12	9174-9177	are	_
48-13	9178-9189	significant	_
48-14	9190-9192	in	_
48-15	9193-9197	both	_
48-16	9198-9200	of	_
48-17	9201-9204	the	_
48-18	9205-9208	FNC	_
48-19	9209-9214	types	_
48-20	9215-9219	that	_
48-21	9220-9222	we	_
48-22	9223-9226	are	_
48-23	9227-9236	comparing	_
48-24	9237-9238	)	_
48-25	9239-9240	,	_
48-26	9241-9243	we	_
48-27	9244-9252	retained	_
48-28	9253-9266	network-pairs	_
48-29	9267-9272	whose	_
48-30	9273-9285	connectivity	_
48-31	9286-9289	had	_
48-32	9290-9293	the	_
48-33	9294-9298	same	_
48-34	9299-9313	directionality	_
48-35	9314-9315	(	_
48-36	9316-9324	positive	_
48-37	9325-9327	or	_
48-38	9328-9336	negative	_
48-39	9337-9338	)	_
48-40	9339-9342	and	_
48-41	9343-9347	also	_
48-42	9348-9352	were	_
48-43	9353-9364	significant	_
48-44	9365-9367	in	_
48-45	9368-9372	both	_
48-46	9373-9376	FNC	_
48-47	9377-9385	matrices	_
48-48	9386-9387	(	_
48-49	9388-9391	the	_
48-50	9392-9395	two	_
48-51	9396-9400	FNCs	_
48-52	9401-9405	that	_
48-53	9406-9408	we	_
48-54	9409-9412	are	_
48-55	9413-9422	comparing	_
48-56	9423-9424	)	_
48-57	9425-9426	.	_

49-1	9427-9429	We	_
49-2	9430-9434	were	_
49-3	9435-9445	interested	_
49-4	9446-9448	in	_
49-5	9449-9461	connectivity	_
49-6	9462-9470	strength	_
49-7	9471-9472	(	_
49-8	9473-9475	as	_
49-9	9476-9480	long	_
49-10	9481-9483	as	_
49-11	9484-9486	it	_
49-12	9487-9490	was	_
49-13	9491-9494	the	_
49-14	9495-9499	same	_
49-15	9500-9502	in	_
49-16	9503-9507	both	_
49-17	9508-9511	FNC	_
49-18	9512-9517	types	_
49-19	9518-9519	)	_
49-20	9520-9521	,	_
49-21	9522-9524	so	_
49-22	9525-9528	the	_
49-23	9529-9541	network-pair	_
49-24	9542-9554	connectivity	_
49-25	9555-9558	was	_
49-26	9559-9563	then	_
49-27	9564-9573	converted	_
49-28	9574-9576	to	_
49-29	9577-9585	absolute	_
49-30	9586-9592	values	_
49-31	9593-9594	.	_

50-1	9595-9598	For	_
50-2	9599-9603	each	_
50-3	9604-9608	pair	_
50-4	9609-9611	of	_
50-5	9612-9615	FNC	_
50-6	9616-9621	types	_
50-7	9622-9623	,	_
50-8	9624-9625	a	_
50-9	9626-9632	paired	_
50-10	9633-9639	t-test	_
50-11	9640-9642	on	_
50-12	9643-9653	magnitudes	_
50-13	9654-9657	was	_
50-14	9658-9662	then	_
50-15	9663-9672	performed	_
50-16	9673-9674	.	_

51-1	9675-9682	Results	_
51-2	9683-9687	were	_
51-3	9688-9697	corrected	_
51-4	9698-9702	with	_
51-5	9703-9707	0.05	_
51-6	9708-9714	levels	_
51-7	9715-9718	FDR	_
51-8	9719-9720	.	_

52-1	9721-9726	Later	_
52-2	9727-9728	,	_
52-3	9729-9732	for	_
52-4	9733-9740	patient	_
52-5	9741-9744	and	_
52-6	9745-9752	control	_
52-7	9753-9759	groups	_
52-8	9760-9770	separately	_
52-9	9771-9772	,	_
52-10	9773-9775	we	_
52-11	9776-9786	identified	_
52-12	9787-9790	the	_
52-13	9791-9797	number	_
52-14	9798-9800	of	_
52-15	9801-9812	significant	_
52-16	9813-9826	network-pairs	_
52-17	9827-9830	and	_
52-18	9831-9839	recorded	_
52-19	9840-9845	which	_
52-20	9846-9849	FNC	_
52-21	9850-9854	type	_
52-22	9855-9859	they	_
52-23	9860-9867	favored	_
52-24	9868-9869	.	_

53-1	9870-9878	Modeling	_
53-2	9879-9882	Age	_
53-3	9883-9884	,	_
53-4	9885-9891	Gender	_
53-5	9892-9893	,	_
53-6	9894-9907	Schizophrenia	_
53-7	9908-9911	and	_
53-8	9912-9922	Handedness	_
53-9	9923-9930	Effects	_
53-10	9931-9933	in	_
53-11	9934-9939	Intra	_
53-12	9940-9943	FNC	_
53-13	9944-9955	Differences	_
53-14	9956-9958	In	_
53-15	9959-9964	order	_
53-16	9965-9967	to	_
53-17	9968-9979	investigate	_
53-18	9980-9983	the	_
53-19	9984-9995	differences	_
53-20	9996-10003	between	_
53-21	10004-10008	left	_
53-22	10009-10012	and	_
53-23	10013-10018	right	_
53-24	10019-10038	hemisphere-specific	_
53-25	10039-10043	FNCs	_
53-26	10044-10045	,	_
53-27	10046-10047	a	_
53-28	10048-10058	left-right	_
53-29	10059-10062	FNC	_
53-30	10063-10073	difference	_
53-31	10074-10077	map	_
53-32	10078-10081	was	_
53-33	10082-10092	calculated	_
53-34	10093-10096	for	_
53-35	10097-10101	each	_
53-36	10102-10109	subject	_
53-37	10110-10111	(	_
53-38	10112-10117	L_FNC	_
53-39	10118-10123	minus	_
53-40	10124-10129	R_FNC	_
53-41	10130-10131	)	_
53-42	10132-10133	.	_

54-1	10134-10137	The	_
54-2	10138-10144	values	_
54-3	10145-10149	from	_
54-4	10150-10154	this	_
54-5	10155-10165	difference	_
54-6	10166-10169	map	_
54-7	10170-10174	were	_
54-8	10175-10179	then	_
54-9	10180-10192	individually	_
54-10	10193-10201	employed	_
54-11	10202-10204	as	_
54-12	10205-10208	the	_
54-13	10209-10218	dependent	_
54-14	10219-10227	variable	_
54-15	10228-10230	in	_
54-16	10231-10232	a	_
54-17	10233-10241	multiple	_
54-18	10242-10248	linear	_
54-19	10249-10259	regression	_
54-20	10260-10262	on	_
54-21	10263-10266	age	_
54-22	10267-10268	,	_
54-23	10269-10275	gender	_
54-24	10276-10277	,	_
54-25	10278-10291	schizophrenia	_
54-26	10292-10293	,	_
54-27	10294-10304	handedness	_
54-28	10305-10306	,	_
54-29	10307-10310	and	_
54-30	10311-10316	sites	_
54-31	10317-10318	,	_
54-32	10319-10321	as	_
54-33	10322-10326	well	_
54-34	10327-10329	as	_
54-35	10330-10336	motion	_
54-36	10337-10347	parameters	_
54-37	10348-10349	.	_

55-1	10350-10352	We	_
55-2	10353-10359	prefer	_
55-3	10360-10363	the	_
55-4	10364-10374	regression	_
55-5	10375-10381	method	_
55-6	10382-10384	in	_
55-7	10385-10390	order	_
55-8	10391-10393	to	_
55-9	10394-10401	regress	_
55-10	10402-10405	out	_
55-11	10406-10409	the	_
55-12	10410-10416	motion	_
55-13	10417-10418	,	_
55-14	10419-10423	site	_
55-15	10424-10426	ID	_
55-16	10427-10430	and	_
55-17	10431-10441	handedness	_
55-18	10442-10448	effect	_
55-19	10449-10451	on	_
55-20	10452-10455	the	_
55-21	10456-10467	differences	_
55-22	10468-10469	.	_

56-1	10470-10473	The	_
56-2	10474-10479	model	_
56-3	10480-10484	used	_
56-4	10485-10487	is	_
56-5	10488-10498	formulized	_
56-6	10499-10504	below	_
56-7	10505-10506	:	_
56-8	10507-10511	Xgen	_
56-9	10512-10514	is	_
56-10	10515-10516	a	_
56-11	10517-10528	categorical	_
56-12	10529-10537	variable	_
56-13	10538-10550	representing	_
56-14	10551-10554	the	_
56-15	10555-10561	gender	_
56-16	10562-10564	of	_
56-17	10565-10572	subject	_
56-18	10573-10577	with	_
56-19	10578-10579	1	_
56-20	10580-10583	for	_
56-21	10584-10591	females	_
56-22	10592-10595	and	_
56-23	10596-10597	0	_
56-24	10598-10601	for	_
56-25	10602-10607	males	_
56-26	10608-10614	before	_
56-27	10615-10619	mean	_
56-28	10620-10627	removal	_
56-29	10628-10629	.	_

57-1	10630-10633	The	_
57-2	10634-10637	age	_
57-3	10638-10639	(	_
57-4	10640-10644	Xage	_
57-5	10645-10646	)	_
57-6	10647-10649	is	_
57-7	10650-10653	the	_
57-8	10654-10662	demeaned	_
57-9	10663-10670	subject	_
57-10	10671-10674	age	_
57-11	10675-10676	;	_
57-12	10677-10682	Xdiag	_
57-13	10683-10685	is	_
57-14	10686-10687	1	_
57-15	10688-10691	for	_
57-16	10692-10705	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
57-17	10706-10714	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
57-18	10715-10718	and	_
57-19	10719-10720	0	_
57-20	10721-10723	is	_
57-21	10724-10727	for	_
57-22	10728-10735	healthy	_
57-23	10736-10743	control	_
57-24	10744-10750	before	_
57-25	10751-10755	mean	_
57-26	10756-10763	removal	_
57-27	10764-10765	.	_

58-1	10766-10776	Handedness	_
58-2	10777-10779	is	_
58-3	10780-10783	the	_
58-4	10784-10791	subject	_
58-5	10792-10793	’	_
58-6	10794-10795	s	_
58-7	10796-10804	Edinburg	_
58-8	10805-10815	handedness	_
58-9	10816-10821	score	_
58-10	10822-10828	ranges	_
58-11	10829-10836	between	_
58-12	10837-10839	-2	_
58-13	10840-10843	and	_
58-14	10844-10845	2	_
58-15	10846-10847	(	_
58-16	10848-10856	positive	_
58-17	10857-10860	for	_
58-18	10861-10866	right	_
58-19	10867-10874	handers	_
58-20	10875-10876	)	_
58-21	10877-10883	before	_
58-22	10884-10888	mean	_
58-23	10889-10896	removal	_
58-24	10897-10898	;	_
58-25	10899-10903	Xmot	_
58-26	10904-10906	is	_
58-27	10907-10910	the	_
58-28	10911-10919	demeaned	_
58-29	10920-10924	mean	_
58-30	10925-10930	frame	_
58-31	10931-10943	displacement	_
58-32	10944-10945	;	_
58-33	10946-10949	and	_
58-34	10950-10956	Xsite1	_
58-35	10957-10958	,	_
58-36	10959-10960	2	_
58-37	10961-10962	,	_
58-38	10963-10965	…6	_
58-39	10966-10969	are	_
58-40	10970-10975	dummy	_
58-41	10976-10981	coded	_
58-42	10982-10986	site	_
58-43	10987-10996	variables	_
58-44	10997-10998	(	_
58-45	10999-11002	six	_
58-46	11003-11007	site	_
58-47	11008-11017	variables	_
58-48	11018-11023	coded	_
58-49	11024-11028	with	_
58-50	11029-11030	1	_
58-51	11031-11034	for	_
58-52	11035-11038	the	_
58-53	11039-11043	site	_
58-54	11044-11047	and	_
58-55	11048-11050	0s	_
58-56	11051-11054	for	_
58-57	11055-11058	the	_
58-58	11059-11065	others	_
58-59	11066-11067	,	_
58-60	11068-11073	while	_
58-61	11074-11078	site	_
58-62	11079-11080	7	_
58-63	11081-11092	represented	_
58-64	11093-11095	as	_
58-65	11096-11099	all	_
58-66	11100-11102	0s	_
58-67	11103-11104	)	_
58-68	11105-11117	representing	_
58-69	11118-11123	seven	_
58-70	11124-11133	different	_
58-71	11134-11138	data	_
58-72	11139-11144	sites	_
58-73	11145-11146	;	_
58-74	11147-11151	each	_
58-75	11152-11160	variable	_
58-76	11161-11164	was	_
58-77	11165-11169	also	_
58-78	11170-11178	demeaned	_
58-79	11179-11180	.	_

59-1	11181-11184	All	_
59-2	11185-11186	β	_
59-3	11187-11188	’	_
59-4	11189-11190	s	_
59-5	11191-11194	are	_
59-6	11195-11198	the	_
59-7	11199-11211	coefficients	_
59-8	11212-11214	of	_
59-9	11215-11218	the	_
59-10	11219-11229	regression	_
59-11	11230-11235	model	_
59-12	11236-11237	,	_
59-13	11238-11242	with	_
59-14	11243-11244	ɛ	_
59-15	11245-11250	being	_
59-16	11251-11254	the	_
59-17	11255-11260	error	_
59-18	11261-11270	parameter	_
59-19	11271-11274	for	_
59-20	11275-11278	the	_
59-21	11279-11284	model	_
59-22	11285-11286	,	_
59-23	11287-11290	and	_
59-24	11291-11292	σ	_
59-25	11293-11294	(	_
59-26	11295-11296	i	_
59-27	11297-11298	,	_
59-28	11299-11300	j	_
59-29	11301-11302	)	_
59-30	11303-11305	is	_
59-31	11306-11309	the	_
59-32	11310-11320	difference	_
59-33	11321-11328	between	_
59-34	11329-11334	L_FNC	_
59-35	11335-11338	and	_
59-36	11339-11344	R_FNC	_
59-37	11345-11346	.	_

60-1	11347-11351	This	_
60-2	11352-11360	analysis	_
60-3	11361-11369	captures	_
60-4	11370-11373	the	_
60-5	11374-11381	network	_
60-6	11382-11387	pairs	_
60-7	11388-11391	for	_
60-8	11392-11397	which	_
60-9	11398-11401	the	_
60-10	11402-11413	differences	_
60-11	11414-11416	in	_
60-12	11417-11427	left/right	_
60-13	11428-11447	hemisphere-specific	_
60-14	11448-11460	connectivity	_
60-15	11461-11464	are	_
60-16	11465-11478	significantly	_
60-17	11479-11487	affected	_
60-18	11488-11489	(	_
60-19	11490-11491	p	_
60-20	11492-11493	<	_
60-21	11494-11498	0.05	_
60-22	11499-11500	,	_
60-23	11501-11510	following	_
60-24	11511-11516	false	_
60-25	11517-11526	discovery	_
60-26	11527-11531	rate	_
60-27	11532-11533	(	_
60-28	11534-11537	FDR	_
60-29	11538-11539	)	_
60-30	11540-11550	correction	_
60-31	11551-11554	for	_
60-32	11555-11563	multiple	_
60-33	11564-11575	comparisons	_
60-34	11576-11577	)	_
60-35	11578-11580	by	_
60-36	11581-11584	age	_
60-37	11585-11586	,	_
60-38	11587-11593	gender	_
60-39	11594-11595	,	_
60-40	11596-11605	diagnosis	_
60-41	11606-11607	,	_
60-42	11608-11611	and	_
60-43	11612-11622	handedness	_
60-44	11623-11624	.	_

61-1	11625-11627	To	_
61-2	11628-11635	further	_
61-3	11636-11644	evaluate	_
61-4	11645-11648	the	_
61-5	11649-11655	effect	_
61-6	11656-11658	of	_
61-7	11659-11662	the	_
61-8	11663-11675	scanner/site	_
61-9	11676-11677	,	_
61-10	11678-11680	we	_
61-11	11681-11688	removed	_
61-12	11689-11692	the	_
61-13	11693-11701	subjects	_
61-14	11702-11706	from	_
61-15	11707-11710	the	_
61-16	11711-11720	different	_
61-17	11721-11726	brand	_
61-18	11727-11734	scanner	_
61-19	11735-11738	and	_
61-20	11739-11747	repeated	_
61-21	11748-11751	the	_
61-22	11752-11760	analysis	_
61-23	11761-11765	with	_
61-24	11766-11769	the	_
61-25	11770-11779	remaining	_
61-26	11780-11783	262	_
61-27	11784-11792	subjects	_
61-28	11793-11794	;	_
61-29	11795-11802	results	_
61-30	11803-11807	were	_
61-31	11808-11818	consistent	_
61-32	11819-11823	with	_
61-33	11824-11829	those	_
61-34	11830-11832	of	_
61-35	11833-11836	the	_
61-36	11837-11842	whole	_
61-37	11843-11850	dataset	_
61-38	11851-11852	;	_
61-39	11853-11862	therefore	_
61-40	11863-11864	,	_
61-41	11865-11867	we	_
61-42	11868-11872	kept	_
61-43	11873-11876	the	_
61-44	11877-11885	analysis	_
61-45	11886-11891	using	_
61-46	11892-11895	the	_
61-47	11896-11901	whole	_
61-48	11902-11909	dataset	_
61-49	11910-11911	.	_

62-1	11912-11923	Substantial	_
62-2	11924-11931	efforts	_
62-3	11932-11936	were	_
62-4	11937-11942	taken	_
62-5	11943-11945	to	_
62-6	11946-11952	ensure	_
62-7	11953-11959	motion	_
62-8	11960-11963	was	_
62-9	11964-11967	not	_
62-10	11968-11969	a	_
62-11	11970-11980	confounder	_
62-12	11981-11982	.	_

63-1	11983-11988	First	_
63-2	11989-11990	,	_
63-3	11991-11994	ICA	_
63-4	11995-11997	as	_
63-5	11998-11999	a	_
63-6	12000-12005	whole	_
63-7	12006-12009	has	_
63-8	12010-12014	been	_
63-9	12015-12020	shown	_
63-10	12021-12023	to	_
63-11	12024-12026	be	_
63-12	12027-12031	more	_
63-13	12032-12038	robust	_
63-14	12039-12041	to	_
63-15	12042-12048	motion	_
63-16	12049-12053	than	_
63-17	12054-12064	seed-based	_
63-18	12065-12075	approaches	_
63-19	12076-12078	as	_
63-20	12079-12082	the	_
63-21	12083-12086	ICA	_
63-22	12087-12095	approach	_
63-23	12096-12098	is	_
63-24	12099-12108	naturally	_
63-25	12109-12118	denoising	_
63-26	12119-12122	the	_
63-27	12123-12127	data	_
63-28	12128-12129	.	_

64-1	12130-12132	In	_
64-2	12133-12141	addition	_
64-3	12142-12143	,	_
64-4	12144-12147	the	_
64-5	12148-12151	ICA	_
64-6	12152-12156	time	_
64-7	12157-12163	series	_
64-8	12164-12166	of	_
64-9	12167-12170	the	_
64-10	12171-12175	RSNs	_
64-11	12176-12180	were	_
64-12	12181-12190	detrended	_
64-13	12191-12194	and	_
64-14	12195-12209	orthogonalized	_
64-15	12210-12214	with	_
64-16	12215-12222	respect	_
64-17	12223-12225	to	_
64-18	12226-12235	estimated	_
64-19	12236-12242	motion	_
64-20	12243-12253	parameters	_
64-21	12254-12255	(	_
64-22	12256-12265	including	_
64-23	12266-12271	their	_
64-24	12272-12283	derivatives	_
64-25	12284-12285	,	_
64-26	12286-12291	their	_
64-27	12292-12299	squares	_
64-28	12300-12303	and	_
64-29	12304-12315	derivatives	_
64-30	12316-12318	of	_
64-31	12319-12322	the	_
64-32	12323-12330	squares	_
64-33	12331-12332	)	_
64-34	12333-12336	and	_
64-35	12337-12345	despiked	_
64-36	12346-12347	(	_
64-37	12348-12349	a	_
64-38	12350-12354	step	_
64-39	12355-12360	which	_
64-40	12361-12363	is	_
64-41	12364-12371	similar	_
64-42	12372-12374	to	_
64-43	12375-12384	scrubbing	_
64-44	12385-12386	)	_
64-45	12387-12388	.	_

65-1	12389-12391	In	_
65-2	12392-12400	addition	_
65-3	12401-12402	,	_
65-4	12403-12409	motion	_
65-5	12410-12420	parameters	_
65-6	12421-12425	were	_
65-7	12426-12431	added	_
65-8	12432-12434	as	_
65-9	12435-12443	nuisance	_
65-10	12444-12454	covariates	_
65-11	12455-12457	in	_
65-12	12458-12463	order	_
65-13	12464-12466	to	_
65-14	12467-12475	mitigate	_
65-15	12476-12483	against	_
65-16	12484-12492	residual	_
65-17	12493-12499	motion	_
65-18	12500-12507	effects	_
65-19	12508-12509	.	_

66-1	12510-12512	We	_
66-2	12513-12517	also	_
66-3	12518-12525	checked	_
66-4	12526-12529	the	_
66-5	12530-12536	motion	_
66-6	12537-12548	differences	_
66-7	12549-12556	between	_
66-8	12557-12570	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
66-9	12571-12579	patients	_
66-10	12580-12583	and	_
66-11	12584-12591	healthy	_
66-12	12592-12599	control	_
66-13	12600-12602	on	_
66-14	12603-12607	mean	_
66-15	12608-12613	frame	_
66-16	12614-12626	displacement	_
66-17	12627-12632	using	_
66-18	12633-12634	a	_
66-19	12635-12645	two-sample	_
66-20	12646-12652	t-test	_
66-21	12653-12654	.	_

67-1	12655-12662	Results	_
67-2	12663-12672	indicated	_
67-3	12673-12686	significantly	_
67-4	12687-12693	higher	_
67-5	12694-12700	motion	_
67-6	12701-12703	in	_
67-7	12704-12712	patients	_
67-8	12713-12717	than	_
67-9	12718-12726	controls	_
67-10	12727-12728	(	_
67-11	12729-12732	For	_
67-12	12733-12736	all	_
67-13	12737-12745	subjects	_
67-14	12746-12747	;	_
67-15	12748-12752	mean	_
67-16	12753-12754	=	_
67-17	12755-12761	0.2947	_
67-18	12762-12763	,	_
67-19	12764-12766	sd	_
67-20	12767-12768	=	_
67-21	12769-12775	0.1308	_
67-22	12776-12777	,	_
67-23	12778-12783	group	_
67-24	12784-12794	difference	_
67-25	12795-12796	p	_
67-26	12797-12798	=	_
67-27	12799-12809	4.6440e-04	_
67-28	12810-12811	;	_
67-29	12812-12815	for	_
67-30	12816-12819	163	_
67-31	12820-12827	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
67-32	12828-12836	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
67-33	12837-12838	,	_
67-34	12839-12843	mean	_
67-35	12844-12845	=	_
67-36	12846-12850	0.27	_
67-37	12851-12852	,	_
67-38	12853-12855	sd	_
67-39	12856-12857	=	_
67-40	12858-12864	0.1214	_
67-41	12865-12866	;	_
67-42	12867-12870	for	_
67-43	12871-12874	151	_
67-44	12875-12883	patients	_
67-45	12884-12885	,	_
67-46	12886-12891	mean=	_
67-47	12892-12898	0.3213	_
67-48	12899-12900	,	_
67-49	12901-12903	sd	_
67-50	12904-12905	=	_
67-51	12906-12912	0.1356	_
67-52	12913-12914	)	_
67-53	12915-12916	.	_

68-1	12917-12922	After	_
68-2	12923-12932	excluding	_
68-3	12933-12941	subjects	_
68-4	12942-12947	whose	_
68-5	12948-12952	mean	_
68-6	12953-12958	frame	_
68-7	12959-12971	displacement	_
68-8	12972-12975	was	_
68-9	12976-12983	greater	_
68-10	12984-12988	than	_
68-11	12989-12993	0.45	_
68-12	12994-12996	mm	_
68-13	12997-12998	,	_
68-14	12999-13002	the	_
68-15	13003-13012	remaining	_
68-16	13013-13016	150	_
68-17	13017-13024	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
68-18	13025-13033	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
68-19	13034-13035	(	_
68-20	13036-13045	initially	_
68-21	13046-13049	163	_
68-22	13050-13051	)	_
68-23	13052-13055	and	_
68-24	13056-13059	118	_
68-25	13060-13073	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
68-26	13074-13082	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
68-27	13083-13084	(	_
68-28	13085-13094	initially	_
68-29	13095-13098	151	_
68-30	13099-13100	)	_
68-31	13101-13104	did	_
68-32	13105-13108	not	_
68-33	13109-13113	have	_
68-34	13114-13115	a	_
68-35	13116-13127	significant	_
68-36	13128-13132	mean	_
68-37	13133-13138	frame	_
68-38	13139-13151	displacement	_
68-39	13152-13162	difference	_
68-40	13163-13164	(	_
68-41	13165-13168	For	_
68-42	13169-13174	these	_
68-43	13175-13178	268	_
68-44	13179-13187	subjects	_
68-45	13188-13189	;	_
68-46	13190-13194	mean	_
68-47	13195-13196	=	_
68-48	13197-13203	0.2541	_
68-49	13204-13205	,	_
68-50	13206-13208	sd	_
68-51	13209-13210	=	_
68-52	13211-13217	0.0889	_
68-53	13218-13219	,	_
68-54	13220-13225	group	_
68-55	13226-13236	difference	_
68-56	13237-13238	p	_
68-57	13239-13240	=	_
68-58	13241-13247	0.1144	_
68-59	13248-13249	;	_
68-60	13250-13253	for	_
68-61	13254-13257	150	_
68-62	13258-13265	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
68-63	13266-13274	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
68-64	13275-13276	,	_
68-65	13277-13281	mean	_
68-66	13282-13283	=	_
68-67	13284-13290	0.2464	_
68-68	13291-13292	,	_
68-69	13293-13295	sd	_
68-70	13296-13297	=	_
68-71	13298-13304	0.0923	_
68-72	13305-13306	;	_
68-73	13307-13310	for	_
68-74	13311-13314	118	_
68-75	13315-13323	patients	_
68-76	13324-13325	,	_
68-77	13326-13330	mean	_
68-78	13331-13332	=	_
68-79	13333-13339	0.2637	_
68-80	13340-13341	,	_
68-81	13342-13344	sd	_
68-82	13345-13346	=	_
68-83	13347-13353	0.0838	_
68-84	13354-13355	)	_
68-85	13356-13357	.	_

69-1	13358-13360	We	_
69-2	13361-13369	repeated	_
69-3	13370-13373	the	_
69-4	13374-13382	analysis	_
69-5	13383-13387	with	_
69-6	13388-13391	the	_
69-7	13392-13400	retained	_
69-8	13401-13404	268	_
69-9	13405-13413	subjects	_
69-10	13414-13415	;	_
69-11	13416-13419	and	_
69-12	13420-13425	found	_
69-13	13426-13430	that	_
69-14	13431-13434	the	_
69-15	13435-13442	results	_
69-16	13443-13447	were	_
69-17	13448-13458	consistent	_
69-18	13459-13463	with	_
69-19	13464-13469	those	_
69-20	13470-13472	of	_
69-21	13473-13476	the	_
69-22	13477-13482	whole	_
69-23	13483-13490	dataset	_
69-24	13491-13492	.	_

70-1	13493-13495	In	_
70-2	13496-13504	addition	_
70-3	13505-13506	,	_
70-4	13507-13509	an	_
70-5	13510-13515	ANOVA	_
70-6	13516-13520	test	_
70-7	13521-13530	comparing	_
70-8	13531-13535	mean	_
70-9	13536-13541	frame	_
70-10	13542-13554	displacement	_
70-11	13555-13562	between	_
70-12	13563-13568	sites	_
70-13	13569-13575	showed	_
70-14	13576-13577	a	_
70-15	13578-13589	significant	_
70-16	13590-13594	site	_
70-17	13595-13605	difference	_
70-18	13606-13607	.	_

71-1	13608-13610	To	_
71-2	13611-13618	further	_
71-3	13619-13624	check	_
71-4	13625-13628	how	_
71-5	13629-13633	this	_
71-6	13634-13642	impacted	_
71-7	13643-13646	the	_
71-8	13647-13654	results	_
71-9	13655-13656	,	_
71-10	13657-13659	we	_
71-11	13660-13668	excluded	_
71-12	13669-13672	the	_
71-13	13673-13677	site	_
71-14	13678-13682	with	_
71-15	13683-13686	the	_
71-16	13687-13696	different	_
71-17	13697-13701	mean	_
71-18	13702-13707	frame	_
71-19	13708-13720	displacement	_
71-20	13721-13722	(	_
71-21	13723-13726	the	_
71-22	13727-13731	only	_
71-23	13732-13734	GE	_
71-24	13735-13742	scanner	_
71-25	13743-13744	)	_
71-26	13745-13748	and	_
71-27	13749-13757	repeated	_
71-28	13758-13761	the	_
71-29	13762-13767	ANOVA	_
71-30	13768-13772	test	_
71-31	13773-13774	,	_
71-32	13775-13780	which	_
71-33	13781-13787	showed	_
71-34	13788-13792	that	_
71-35	13793-13796	the	_
71-36	13797-13802	means	_
71-37	13803-13807	were	_
71-38	13808-13810	no	_
71-39	13811-13817	longer	_
71-40	13818-13831	significantly	_
71-41	13832-13841	different	_
71-42	13842-13849	between	_
71-43	13850-13855	sites	_
71-44	13856-13857	(	_
71-45	13858-13866	p=0.1683	_
71-46	13867-13868	)	_
71-47	13869-13870	.	_

72-1	13871-13879	Analysis	_
72-2	13880-13885	using	_
72-3	13886-13889	the	_
72-4	13890-13893	six	_
72-5	13894-13899	sites	_
72-6	13900-13904	with	_
72-7	13905-13908	the	_
72-8	13909-13913	same	_
72-9	13914-13919	brand	_
72-10	13920-13927	scanner	_
72-11	13928-13934	showed	_
72-12	13935-13942	results	_
72-13	13943-13953	consistent	_
72-14	13954-13958	with	_
72-15	13959-13964	those	_
72-16	13965-13967	of	_
72-17	13968-13971	the	_
72-18	13972-13977	whole	_
72-19	13978-13985	dataset	_
72-20	13986-13987	.	_

73-1	13988-13996	Modeling	_
73-2	13997-14000	Age	_
73-3	14001-14002	,	_
73-4	14003-14009	Gender	_
73-5	14010-14011	,	_
73-6	14012-14025	Schizophrenia	_
73-7	14026-14029	and	_
73-8	14030-14040	Handedness	_
73-9	14041-14048	Effects	_
73-10	14049-14051	in	_
73-11	14052-14057	Intra	_
73-12	14058-14068	Hemisphere	_
73-13	14069-14072	and	_
73-14	14073-14078	Inter	_
73-15	14079-14089	Hemisphere	_
73-16	14090-14093	FNC	_
73-17	14094-14096	We	_
73-18	14097-14101	also	_
73-19	14102-14110	examined	_
73-20	14111-14114	the	_
73-21	14115-14122	effects	_
73-22	14123-14125	of	_
73-23	14126-14129	age	_
73-24	14130-14131	,	_
73-25	14132-14138	gender	_
73-26	14139-14140	,	_
73-27	14141-14150	diagnosis	_
73-28	14151-14154	and	_
73-29	14155-14165	handedness	_
73-30	14166-14168	on	_
73-31	14169-14172	the	_
73-32	14173-14192	hemisphere-specific	_
73-33	14193-14197	FNCs	_
73-34	14198-14199	(	_
73-35	14200-14205	L_FNC	_
73-36	14206-14209	and	_
73-37	14210-14215	R_FNC	_
73-38	14216-14217	)	_
73-39	14218-14221	and	_
73-40	14222-14224	on	_
73-41	14225-14228	the	_
73-42	14229-14238	Inter_FNC	_
73-43	14239-14240	.	_

74-1	14241-14243	We	_
74-2	14244-14248	used	_
74-3	14249-14250	a	_
74-4	14251-14258	similar	_
74-5	14259-14269	regression	_
74-6	14270-14275	model	_
74-7	14276-14278	as	_
74-8	14279-14288	described	_
74-9	14289-14294	above	_
74-10	14295-14296	,	_
74-11	14297-14301	with	_
74-12	14302-14303	σ	_
74-13	14304-14305	(	_
74-14	14306-14307	i	_
74-15	14308-14309	,	_
74-16	14310-14311	j	_
74-17	14312-14313	)	_
74-18	14314-14319	being	_
74-19	14320-14323	the	_
74-20	14324-14330	intra-	_
74-21	14331-14333	or	_
74-22	14334-14343	inter-FNC	_
74-23	14344-14349	value	_
74-24	14350-14356	rather	_
74-25	14357-14361	than	_
74-26	14362-14365	the	_
74-27	14366-14377	differences	_
74-28	14378-14379	.	_

75-1	14380-14392	Significance	_
75-2	14393-14396	for	_
75-3	14397-14401	beta	_
75-4	14402-14408	values	_
75-5	14409-14412	was	_
75-6	14413-14418	later	_
75-7	14419-14430	thresholded	_
75-8	14431-14435	with	_
75-9	14436-14440	0.05	_
75-10	14441-14447	levels	_
75-11	14448-14451	FDR	_
75-12	14452-14453	.	_

76-1	14454-14457	Age	_
76-2	14458-14461	and	_
76-3	14462-14468	gender	_
76-4	14469-14476	results	_
76-5	14477-14479	on	_
76-6	14480-14486	intra-	_
76-7	14487-14490	and	_
76-8	14491-14500	inter-FNC	_
76-9	14501-14504	are	_
76-10	14505-14514	presented	_
76-11	14515-14517	in	_
76-12	14518-14531	supplementary	_
76-13	14532-14541	materials	_
76-14	14542-14543	.	_

77-1	14544-14552	Modeling	_
77-2	14553-14560	Effects	_
77-3	14561-14563	of	_
77-4	14564-14573	Cognitive	_
77-5	14574-14580	Scores	_
77-6	14581-14582	,	_
77-7	14583-14590	Symptom	_
77-8	14591-14597	Scores	_
77-9	14598-14601	and	_
77-10	14602-14606	Mean	_
77-11	14607-14620	Antipsychotic	_
77-12	14621-14625	Dose	_
77-13	14626-14628	We	_
77-14	14629-14637	examined	_
77-15	14638-14641	the	_
77-16	14642-14648	effect	_
77-17	14649-14651	of	_
77-18	14652-14661	cognitive	_
77-19	14662-14668	scores	_
77-20	14669-14670	(	_
77-21	14671-14677	CMINDS	_
77-22	14678-14679	)	_
77-23	14680-14681	,	_
77-24	14682-14689	symptom	_
77-25	14690-14695	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
77-26	14696-14702	scores	_
77-27	14703-14704	,	_
77-28	14705-14708	and	_
77-29	14709-14713	mean	_
77-30	14714-14727	antipsychotic	_
77-31	14728-14732	dose	_
77-32	14733-14734	(	_
77-33	14735-14738	CPZ	_
77-34	14739-14749	equivalent	_
77-35	14750-14751	)	_
77-36	14752-14754	in	_
77-37	14755-14763	separate	_
77-38	14764-14774	regression	_
77-39	14775-14783	analysis	_
77-40	14784-14786	on	_
77-41	14787-14793	intra-	_
77-42	14794-14797	and	_
77-43	14798-14808	inter-FNCs	_
77-44	14809-14812	and	_
77-45	14813-14816	the	_
77-46	14817-14827	left-right	_
77-47	14828-14838	difference	_
77-48	14839-14843	FNCs	_
77-49	14844-14845	.	_

78-1	14846-14854	Analysis	_
78-2	14855-14857	of	_
78-3	14858-14867	Euclidian	_
78-4	14868-14876	Distance	_
78-5	14877-14880	and	_
78-6	14881-14893	Connectivity	_
78-7	14894-14902	Strength	_
78-8	14903-14907	Some	_
78-9	14908-14915	studies	_
78-10	14916-14920	have	_
78-11	14921-14929	reported	_
78-12	14930-14932	an	_
78-13	14933-14940	inverse	_
78-14	14941-14953	relationship	_
78-15	14954-14961	between	_
78-16	14962-14970	regional	_
78-17	14971-14979	distance	_
78-18	14980-14983	and	_
78-19	14984-14996	connectivity	_
78-20	14997-15005	strength	_
78-21	15006-15007	.	_

79-1	15008-15010	We	_
79-2	15011-15019	examined	_
79-3	15020-15027	whether	_
79-4	15028-15036	distance	_
79-5	15037-15040	was	_
79-6	15041-15042	a	_
79-7	15043-15049	factor	_
79-8	15050-15052	in	_
79-9	15053-15064	determining	_
79-10	15065-15077	connectivity	_
79-11	15078-15086	strength	_
79-12	15087-15092	using	_
79-13	15093-15094	a	_
79-14	15095-15101	linear	_
79-15	15102-15112	regression	_
79-16	15113-15118	model	_
79-17	15119-15120	.	_

80-1	15121-15123	We	_
80-2	15124-15129	first	_
80-3	15130-15140	calculated	_
80-4	15141-15144	the	_
80-5	15145-15151	center	_
80-6	15152-15154	of	_
80-7	15155-15159	mass	_
80-8	15160-15162	of	_
80-9	15163-15166	the	_
80-10	15167-15177	components	_
80-11	15178-15181	and	_
80-12	15182-15186	then	_
80-13	15187-15190	the	_
80-14	15191-15200	Euclidian	_
80-15	15201-15210	distances	_
80-16	15211-15218	between	_
80-17	15219-15222	the	_
80-18	15223-15233	components	_
80-19	15234-15236	in	_
80-20	15237-15241	left	_
80-21	15242-15245	and	_
80-22	15246-15251	right	_
80-23	15252-15262	aggregated	_
80-24	15263-15267	maps	_
80-25	15268-15269	.	_

81-1	15270-15272	We	_
81-2	15273-15283	separately	_
81-3	15284-15292	analyzed	_
81-4	15293-15296	the	_
81-5	15297-15306	homotopic	_
81-6	15307-15314	regions	_
81-7	15315-15318	and	_
81-8	15319-15330	heterotopic	_
81-9	15331-15338	regions	_
81-10	15339-15344	using	_
81-11	15345-15349	only	_
81-12	15350-15353	the	_
81-13	15354-15365	significant	_
81-14	15366-15379	network-pairs	_
81-15	15380-15381	(	_
81-16	15382-15392	determined	_
81-17	15393-15395	by	_
81-18	15396-15399	one	_
81-19	15400-15406	sample	_
81-20	15407-15414	t-tests	_
81-21	15415-15423	followed	_
81-22	15424-15426	by	_
81-23	15427-15430	FDR	_
81-24	15431-15441	correction	_
81-25	15442-15443	)	_
81-26	15444-15446	in	_
81-27	15447-15448	a	_
81-28	15449-15455	linear	_
81-29	15456-15466	regression	_
81-30	15467-15468	.	_

82-1	15469-15472	For	_
82-2	15473-15484	heterotopic	_
82-3	15485-15493	analysis	_
82-4	15494-15495	,	_
82-5	15496-15500	only	_
82-6	15501-15511	positively	_
82-7	15512-15522	correlated	_
82-8	15523-15528	pairs	_
82-9	15529-15532	are	_
82-10	15533-15541	included	_
82-11	15542-15543	.	_

